• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管疾病与乳腺癌竞争,成为老年女性乳腺癌患者的主要死亡原因:一项回顾性队列研究。

Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.

机构信息

Department of Epidemiology, Colorado School of Public Health, University of Colorado Denver, Aurora, 80045, USA.

出版信息

Breast Cancer Res. 2011 Jun 20;13(3):R64. doi: 10.1186/bcr2901.

DOI:10.1186/bcr2901
PMID:21689398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3218953/
Abstract

INTRODUCTION

Many women who survive breast cancer die of causes unrelated to their cancer diagnosis. This study was undertaken to assess factors that are related to breast cancer mortality versus mortality from other causes and to describe the leading causes of death among older women diagnosed with breast cancer.

METHODS

Women diagnosed with breast cancer at age 66 or older between 1992 and 2000 were identified in the Surveillance, Epidemiology and End Results-Medicare linked database and followed through the end of 2005.

RESULTS

A total of 63,566 women diagnosed with breast cancer met the inclusion criteria and were followed for a median of approximately nine years. Almost one-half (48.7%) were alive at the end of follow-up. Ages and comorbidities at the time of diagnosis had the largest effects on mortality from other causes, while tumor stage, tumor grade, estrogen receptor status, age and comorbidities at the time of diagnosis all had effects on breast cancer-specific mortality. Fully adjusted relative hazards of the effects of comorbidities on breast cancer-specific mortality were 1.24 (95% confidence interval (95% CI) 1.13 to 1.26) for cardiovascular disease, 1.13 (95% CI 1.13 to 1.26) for previous cancer, 1.13 (95% CI 1.05 to 1.22) for chronic obstructive pulmonary disease and 1.10 (95% CI 1.03 to 1.16) for diabetes. Among the total study population, cardiovascular disease was the primary cause of death in the study population (15.9% (95% CI 15.6 to 16.2)), followed closely by breast cancer (15.1% (95% CI 14.8 to 15.4)).

CONCLUSIONS

Comorbid conditions contribute importantly to both total mortality and breast cancer-specific mortality among breast cancer survivors. Attention to reducing the risk of cardiovascular disease should be a priority for the long-term care of women following the diagnosis and treatment of breast cancer.

摘要

引言

许多乳腺癌幸存者死于与癌症诊断无关的原因。本研究旨在评估与乳腺癌死亡率相关的因素与其他原因死亡率,并描述诊断为乳腺癌的老年女性的主要死亡原因。

方法

在监测、流行病学和最终结果-医疗保险数据库中确定了 1992 年至 2000 年间诊断为年龄在 66 岁及以上的乳腺癌女性,并随访至 2005 年底。

结果

共有 63566 名符合纳入标准的乳腺癌患者被纳入研究,并进行了大约九年的中位随访。随访结束时,近一半(48.7%)患者仍然存活。诊断时的年龄和合并症对其他原因导致的死亡率影响最大,而肿瘤分期、肿瘤分级、雌激素受体状态、诊断时的年龄和合并症均对乳腺癌特异性死亡率有影响。合并症对乳腺癌特异性死亡率的完全调整相对危险度为:心血管疾病 1.24(95%置信区间(95%CI)为 1.13 至 1.26),既往癌症为 1.13(95%CI 为 1.13 至 1.26),慢性阻塞性肺疾病为 1.13(95%CI 为 1.05 至 1.22),糖尿病为 1.10(95%CI 为 1.03 至 1.16)。在总研究人群中,心血管疾病是研究人群的主要死亡原因(15.9%(95%CI 为 15.6%至 16.2%)),其次是乳腺癌(15.1%(95%CI 为 14.8%至 15.4%))。

结论

合并症对乳腺癌幸存者的总死亡率和乳腺癌特异性死亡率都有重要影响。在乳腺癌诊断和治疗后,应优先关注降低心血管疾病风险,以作为女性长期护理的重点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3250/3218953/f9b85e724246/bcr2901-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3250/3218953/9bfd6662b86c/bcr2901-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3250/3218953/f9b85e724246/bcr2901-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3250/3218953/9bfd6662b86c/bcr2901-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3250/3218953/f9b85e724246/bcr2901-2.jpg

相似文献

1
Cardiovascular disease competes with breast cancer as the leading cause of death for older females diagnosed with breast cancer: a retrospective cohort study.心血管疾病与乳腺癌竞争,成为老年女性乳腺癌患者的主要死亡原因:一项回顾性队列研究。
Breast Cancer Res. 2011 Jun 20;13(3):R64. doi: 10.1186/bcr2901.
2
Causes of death and relative survival of older women after a breast cancer diagnosis.老年女性乳腺癌诊断后的死因和相对生存率。
J Clin Oncol. 2011 Apr 20;29(12):1570-7. doi: 10.1200/JCO.2010.33.0472. Epub 2011 Mar 14.
3
A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer.基于人群的早期乳腺癌患者心血管死亡率研究。
JAMA Cardiol. 2017 Jan 1;2(1):88-93. doi: 10.1001/jamacardio.2016.3841.
4
Mammography use, breast cancer stage at diagnosis, and survival among older women.老年女性的乳房X光检查使用情况、诊断时的乳腺癌分期及生存率
J Am Geriatr Soc. 2000 Oct;48(10):1226-33. doi: 10.1111/j.1532-5415.2000.tb02595.x.
5
All-Cause and Cardiovascular Disease Mortality Among Breast Cancer Survivors in CLUE II, a Long-Standing Community-Based Cohort.CLUE II 中长期社区队列中乳腺癌幸存者的全因和心血管疾病死亡率。
J Natl Cancer Inst. 2021 Feb 1;113(2):137-145. doi: 10.1093/jnci/djaa096.
6
The influence of comorbidities on overall survival among older women diagnosed with breast cancer.患有乳腺癌的老年女性合并症对总生存的影响。
J Natl Cancer Inst. 2011 Jul 20;103(14):1101-11. doi: 10.1093/jnci/djr188. Epub 2011 Jun 30.
7
Incident comorbidities and all-cause mortality among 5-year survivors of Stage I and II breast cancer diagnosed at age 65 or older: a prospective-matched cohort study.65岁及以上确诊的I期和II期乳腺癌5年幸存者中的共病事件和全因死亡率:一项前瞻性匹配队列研究。
Breast Cancer Res Treat. 2014 Jul;146(2):401-9. doi: 10.1007/s10549-014-3021-8. Epub 2014 Jun 18.
8
Frequency of comorbidities in chronic obstructive pulmonary disease, and impact on all-cause mortality: A population-based cohort study.慢性阻塞性肺疾病合并症的发生率及其对全因死亡率的影响:一项基于人群的队列研究。
Respir Med. 2016 Aug;117:33-9. doi: 10.1016/j.rmed.2016.05.019. Epub 2016 May 20.
9
Hyperthyroidism, Hypothyroidism, and Cause-Specific Mortality in a Large Cohort of Women.甲状腺功能亢进、甲状腺功能减退与特定病因死亡率:一项大型女性队列研究
Thyroid. 2017 Aug;27(8):1001-1010. doi: 10.1089/thy.2017.0063. Epub 2017 Jul 6.
10
Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.年龄及合并症对55岁及以上绝经后乳腺癌患者的影响。
JAMA. 2001 Feb 21;285(7):885-92. doi: 10.1001/jama.285.7.885.

引用本文的文献

1
Take charge during treatment: a protocol for a pilot study to evaluate the impact of exercise on cardiovascular biomarkers among black and white breast cancer patients undergoing treatment.治疗期间负责:一项试点研究方案,以评估运动对接受治疗的黑人和白人乳腺癌患者心血管生物标志物的影响。
Cardiooncology. 2025 Aug 21;11(1):75. doi: 10.1186/s40959-025-00378-7.
2
Greenspace and Survival Among Older Women With Breast Cancer: Regional Variations Within the U.S. SEER-Medicare-Linked Database.美国老年乳腺癌女性的绿地环境与生存率:美国监测、流行病学和最终结果计划(SEER)与医疗保险关联数据库中的区域差异
JACC Adv. 2025 Aug 18;4(9):102069. doi: 10.1016/j.jacadv.2025.102069.
3

本文引用的文献

1
Long-term toxic effects of adjuvant chemotherapy in breast cancer.乳腺癌辅助化疗的长期毒性作用。
Ann Oncol. 2011 Sep;22(9):1939-1947. doi: 10.1093/annonc/mdq683. Epub 2011 Feb 2.
2
Survivorship: adult cancer survivors.生存:成年癌症幸存者。
Prim Care. 2009 Dec;36(4):721-41. doi: 10.1016/j.pop.2009.08.001.
3
Do lifestyle or social factors explain ethnic/racial inequalities in breast cancer survival?生活方式或社会因素能否解释乳腺癌生存中的族裔/种族不平等?
The risk of heart-specific death in breast cancer patients.
乳腺癌患者心脏特异性死亡的风险。
Sci Rep. 2025 Aug 2;15(1):28228. doi: 10.1038/s41598-025-12648-6.
4
Rationale and design of the IMProving Adherence to medications for breast Cancer and cardiovascular disease equiTably (IMPACT) randomized clinical trial.乳腺癌和心血管疾病药物治疗公平性改善(IMPACT)随机临床试验的原理与设计
Contemp Clin Trials. 2025 Jul 11;156:108009. doi: 10.1016/j.cct.2025.108009.
5
Cardiotoxicity in Elderly Breast Cancer Patients.老年乳腺癌患者的心脏毒性
Cancers (Basel). 2025 Jun 30;17(13):2198. doi: 10.3390/cancers17132198.
6
Effects of exercise interventions on bone health and body composition in postmenopausal women with breast cancer: a systematic review and meta-analysis.运动干预对绝经后乳腺癌女性骨骼健康和身体成分的影响:一项系统综述和荟萃分析
Front Oncol. 2025 Jun 18;15:1593165. doi: 10.3389/fonc.2025.1593165. eCollection 2025.
7
Long-term cardiovascular consequences of cancer therapy-related cardiac dysfunction: insights from ventricular-arterial coupling and myocardial work.癌症治疗相关心脏功能障碍的长期心血管后果:来自心室-动脉耦合和心肌做功的见解
Eur Heart J Imaging Methods Pract. 2025 Jun 3;3(1):qyaf072. doi: 10.1093/ehjimp/qyaf072. eCollection 2025 Jan.
8
Supervised high-intensity interval training reduces the negative effect of chemotherapy on cardiorespiratory fitness in young breast cancer women: a randomised controlled study.监督下的高强度间歇训练可降低化疗对年轻乳腺癌女性心肺适能的负面影响:一项随机对照研究。
Eur J Appl Physiol. 2025 Jun 5. doi: 10.1007/s00421-025-05822-1.
9
Applying the unattainable triangle in cardio-oncology care: Balancing cost, quality, and time.在心脏肿瘤学护理中应用难以实现的三角关系:平衡成本、质量和时间。
Oncotarget. 2025 Jun 4;16:419-424. doi: 10.18632/oncotarget.28738.
10
Chemotherapy cardiotoxicity research in cancer patients: a bibliometric and visual analysis (1994-2024).癌症患者化疗心脏毒性研究:文献计量与可视化分析(1994 - 2024年)
Front Oncol. 2025 May 15;15:1502361. doi: 10.3389/fonc.2025.1502361. eCollection 2025.
Epidemiol Rev. 2009;31:52-66. doi: 10.1093/epirev/mxp007. Epub 2009 Aug 12.
4
Symptom experiences and quality of life of rural and urban older adult cancer survivors.农村和城市老年癌症幸存者的症状体验和生活质量。
Cancer Nurs. 2009 Sep-Oct;32(5):359-69. doi: 10.1097/NCC.0b013e3181a52533.
5
Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer.一项乳腺癌延长辅助内分泌治疗随机试验中相互竞争的死亡原因
J Natl Cancer Inst. 2008 Feb 20;100(4):252-60. doi: 10.1093/jnci/djn014. Epub 2008 Feb 12.
6
Time to remove the subspecialty blinders: breast cancer does not exist in isolation.是时候摘掉专科的有色眼镜了:乳腺癌并非孤立存在。
J Natl Cancer Inst. 2008 Feb 20;100(4):230-1. doi: 10.1093/jnci/djn015. Epub 2008 Feb 12.
7
Breast cancer mortality trends in the United States according to estrogen receptor status and age at diagnosis.美国根据雌激素受体状态和诊断时年龄划分的乳腺癌死亡率趋势。
J Clin Oncol. 2007 May 1;25(13):1683-90. doi: 10.1200/JCO.2006.09.2106. Epub 2007 Apr 2.
8
Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients.激素受体状态、肿瘤特征与预后:乳腺癌患者的一项前瞻性队列研究
Breast Cancer Res. 2007;9(1):R6. doi: 10.1186/bcr1639.
9
The effect of medicare health care delivery systems on survival for patients with breast and colorectal cancer.医疗保险医疗服务体系对乳腺癌和结直肠癌患者生存率的影响。
Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):769-73. doi: 10.1158/1055-9965.EPI-05-0838.
10
Comorbidity and survival disparities among black and white patients with breast cancer.乳腺癌黑人和白人患者的合并症与生存差异。
JAMA. 2005 Oct 12;294(14):1765-72. doi: 10.1001/jama.294.14.1765.